PL3500253T3 - Kombinacja odwrotnych agonistów receptora histaminowego-3 z inhibitorami acetylocholinesterazy - Google Patents
Kombinacja odwrotnych agonistów receptora histaminowego-3 z inhibitorami acetylocholinesterazyInfo
- Publication number
- PL3500253T3 PL3500253T3 PL17768234T PL17768234T PL3500253T3 PL 3500253 T3 PL3500253 T3 PL 3500253T3 PL 17768234 T PL17768234 T PL 17768234T PL 17768234 T PL17768234 T PL 17768234T PL 3500253 T3 PL3500253 T3 PL 3500253T3
- Authority
- PL
- Poland
- Prior art keywords
- histamine
- combination
- inverse agonists
- acetylcholinesterase inhibitors
- receptor inverse
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
- 239000002469 receptor inverse agonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641028166 | 2016-08-18 | ||
| EP17768234.1A EP3500253B1 (en) | 2016-08-18 | 2017-08-14 | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors |
| PCT/IB2017/054938 WO2018033847A1 (en) | 2016-08-18 | 2017-08-14 | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3500253T3 true PL3500253T3 (pl) | 2020-11-16 |
Family
ID=59887325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17768234T PL3500253T3 (pl) | 2016-08-18 | 2017-08-14 | Kombinacja odwrotnych agonistów receptora histaminowego-3 z inhibitorami acetylocholinesterazy |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US10603323B2 (pl) |
| EP (1) | EP3500253B1 (pl) |
| JP (1) | JP6734470B2 (pl) |
| KR (1) | KR102039585B1 (pl) |
| CN (1) | CN109640975B (pl) |
| AU (1) | AU2017313427B2 (pl) |
| CA (1) | CA3033039C (pl) |
| CY (1) | CY1123238T1 (pl) |
| DK (1) | DK3500253T3 (pl) |
| EA (1) | EA032957B1 (pl) |
| ES (1) | ES2810983T3 (pl) |
| HR (1) | HRP20201262T1 (pl) |
| HU (1) | HUE052003T2 (pl) |
| IL (1) | IL264406B (pl) |
| LT (1) | LT3500253T (pl) |
| MA (1) | MA45990B1 (pl) |
| MD (1) | MD3500253T2 (pl) |
| ME (1) | ME03812B (pl) |
| MX (1) | MX374114B (pl) |
| NZ (1) | NZ750150A (pl) |
| PL (1) | PL3500253T3 (pl) |
| PT (1) | PT3500253T (pl) |
| RS (1) | RS60669B1 (pl) |
| SG (1) | SG11201900681SA (pl) |
| SI (1) | SI3500253T1 (pl) |
| SM (1) | SMT202000435T1 (pl) |
| WO (1) | WO2018033847A1 (pl) |
| ZA (1) | ZA201900467B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA52850B1 (fr) * | 2018-05-31 | 2025-03-28 | Suven Life Sciences Limited | Méthode de traitement avec un agoniste inverse du récepteur de l'histamine-3 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011013437A (es) * | 2009-06-10 | 2012-02-21 | Sunovion Pharmaceuticals Inc | Antagonista y agonistas inversos de histamina h3 y metodos para el uso de los mismos. |
| JP5805792B2 (ja) * | 2011-02-23 | 2015-11-10 | スヴェン・ライフ・サイエンシズ・リミテッド | ヒスタミンｈ３レセプターリガンドとしての新規な化合物 |
| FR2974729B1 (fr) | 2011-05-02 | 2013-04-19 | Servier Lab | Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent |
| HUP1300139A2 (en) * | 2013-03-06 | 2014-09-29 | Richter Gedeon Nyrt | Phenoxypiperidine h3 antagonists |
| JP2016529307A (ja) | 2013-09-09 | 2016-09-23 | サノフイ | アルツハイマー病の処置に使用するためのｈ３受容体アンタゴニスト |
-
2017
- 2017-08-14 SG SG11201900681SA patent/SG11201900681SA/en unknown
- 2017-08-14 CN CN201780049311.9A patent/CN109640975B/zh active Active
- 2017-08-14 JP JP2019506640A patent/JP6734470B2/ja active Active
- 2017-08-14 HU HUE17768234A patent/HUE052003T2/hu unknown
- 2017-08-14 MX MX2019001696A patent/MX374114B/es active IP Right Grant
- 2017-08-14 PT PT177682341T patent/PT3500253T/pt unknown
- 2017-08-14 SI SI201730360T patent/SI3500253T1/sl unknown
- 2017-08-14 RS RS20200949A patent/RS60669B1/sr unknown
- 2017-08-14 EA EA201990480A patent/EA032957B1/ru unknown
- 2017-08-14 AU AU2017313427A patent/AU2017313427B2/en active Active
- 2017-08-14 SM SM20200435T patent/SMT202000435T1/it unknown
- 2017-08-14 CA CA3033039A patent/CA3033039C/en active Active
- 2017-08-14 EP EP17768234.1A patent/EP3500253B1/en active Active
- 2017-08-14 LT LTEP17768234.1T patent/LT3500253T/lt unknown
- 2017-08-14 PL PL17768234T patent/PL3500253T3/pl unknown
- 2017-08-14 KR KR1020197007056A patent/KR102039585B1/ko active Active
- 2017-08-14 HR HRP20201262TT patent/HRP20201262T1/hr unknown
- 2017-08-14 ES ES17768234T patent/ES2810983T3/es active Active
- 2017-08-14 MA MA45990A patent/MA45990B1/fr unknown
- 2017-08-14 DK DK17768234.1T patent/DK3500253T3/da active
- 2017-08-14 NZ NZ750150A patent/NZ750150A/en unknown
- 2017-08-14 ME MEP-2020-167A patent/ME03812B/me unknown
- 2017-08-14 MD MDE20190714T patent/MD3500253T2/ro unknown
- 2017-08-14 WO PCT/IB2017/054938 patent/WO2018033847A1/en not_active Ceased
- 2017-08-14 US US16/320,949 patent/US10603323B2/en active Active
-
2019
- 2019-01-22 IL IL264406A patent/IL264406B/en active IP Right Grant
- 2019-01-23 ZA ZA2019/00467A patent/ZA201900467B/en unknown
-
2020
- 2020-08-05 CY CY20201100725T patent/CY1123238T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288519B1 (en) | inhibitors of ret | |
| ZA201801750B (en) | Farnesoid x receptor agonists and uses thereof | |
| PL3099720T3 (pl) | Zastosowanie dodatków opartych na kwasach polikarboksylowych do paliw silnikowych | |
| IL279949A (en) | Heterocyclic MCT4 inhibitors | |
| IL284005A (en) | Glucocorticoid receptor inhibitors | |
| IL264628A (en) | Combination of fxr agonists | |
| IL262921B (en) | Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors | |
| GB201417529D0 (en) | Beta lactamase inhibitors | |
| IL264406B (en) | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors | |
| LT3529338T (lt) | Kuro priedų derinys | |
| IL264405B (en) | Triple combination of histamine-3 receptor inverse agonists, acetylcholinesterase inhibitors and nmda receptor antagonist | |
| IL258573A (en) | Inhibitor of the p2x7 receptor | |
| GB201621528D0 (en) | Use of trpv1 agonist |